<DOC>
	<DOCNO>NCT00517634</DOCNO>
	<brief_summary>The aim present study investigate whether effect salmeterol combination fluticasone propionate blood marker airway inflammation maintain chronic dose whether effect influence time allergen challenge relative time dosing .</brief_summary>
	<brief_title>Study Of Fluticasone Propionate/Salmeterol In Asthmatic Subjects</brief_title>
	<detailed_description>A 12-week , randomised , double-blind , placebo-controlled , three-period , cross-over pilot study compare effect salmeterol/fluticasone propionate , fluticasone propionate placebo perpheral blood eosinophil serum IL-5 response allergen challenge asthma subject allergen challenge administer 1 hour 11-12 hour post-dose dose interval</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Fluticasone</mesh_term>
	<mesh_term>Fluticasone Propionate , Salmeterol Xinafoate Drug Combination</mesh_term>
	<mesh_term>Salmeterol Xinafoate</mesh_term>
	<criteria>Informed consent . Outpatient . Male nonpregnant/nonlactating female . Aged 1855 . Diagnosis asthma . Prebronchodilatory FEV1 &gt; 75 % predict . Using inhaled shortacting beta2agonists ( SABA ) inhale corticosteroid . Judged capable withhold SABA least 6 hour prior visit . Reversibility &gt; 12 % 200mL PC20 &lt; 8mg/mL . Demonstration atopy History lifethreatening asthma . Use proscribe asthma medication . Use antihistamines potent inhibitor CYP3A4 . Respiratory tract infection . Asthma exacerbation 4 week Visit 1 . Subjects exercise induce asthma . Concurrent respiratory disease . Other clinically significant , uncontrolled condition disease . Use investigational drug within 30 day . Allergic beta2agonists , inhaled corticosteroid excipients . Positive pregnancy test . Using immunosuppressive medication . Milk protein allergy . Factors likely interfere attendance . Current smoker exsmokers history &gt; 10 pack year . Affiliation wih Investigator site . Medications may affect course asthma interact sympathomimetic amine .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>asthma</keyword>
	<keyword>allergen challenge</keyword>
	<keyword>IL-5</keyword>
	<keyword>eosinophil</keyword>
</DOC>